Clinical Trial Update: Radiation Therapy, Temozolomide, and Erlotinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a combination of radiation therapy, temozolomide, and erlotinib for newly diagnosed glioblastoma multiforme has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Drugs mentioned

• Tarceva (erlotinib)
• Temodar (Temozolomide)

Snippet

Sponsor: David Peereboom | Conditions: CNS Tumor, Adult | Phase 2 | Status: COMPLETED